Krystal Biotech, Inc. (KRYS) Cash flow
Market cap
$10.7B
P/E ratio
| 2017/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | - | - | 2 | 3 | 4 | - | - |
| Stock-based compensation | 0 | 1 | 3 | 15 | 33 | 40 | 49 |
| Cash from operations | -4 | -19 | -26 | -48 | -101 | -89 | 123 |
| Capital expenditures | -0 | -6 | -15 | -68 | -53 | -12 | -4 |
| Cash from investing | -0 | -5 | -11 | -227 | -114 | 83 | -163 |
| Cash from financing | 52 | 108 | 118 | 348 | 35 | 203 | 27 |
| Free cash flow | |||||||
| FCF margin (%) | - | - | - | - | - |